Male Urogen ıtal Dısorders And Metabolıc Syndrome: Possıble Lınks, Characterıstıcs And Potentıal Treatment Strategıes.

CONCLUSION: MetS shows an important association with common male urogenital disorders such as benign prostatic enlargement, lower urinary tract symptoms, erectile dysfunction, infertility and renal disease. MetS affects male urogenital system mainly through endocrine and vascular mechanisms. Obesity, hypogonadism, obesity-induced androgen deficiency, hyperinsulinemia and inflammation are the mechanisms commonly involved and may act as potential targets for MetS-male urogenital system interrelations. Future studies are needed to evaluate the therapeutic approaches for intervention in MetS-male urogenital disease relations. PMID: 29237379 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29237379?dopt=Abstract

Source: Current Pharmaceutical Design - December 12, 2017 Category: Drugs & Pharmacology Authors: Oztekin CV, Kaya E, Yilmaz-Oral D, Gur S Tags: Curr Pharm Des Source Type: research